	Before matching			After matching		
	Target	Comparator		Target	Comparator	
Characteristic	%	%	Std. diff	%	%	Std. diff
Age group	  	  	   	  	  	   
    0 -   4	  	 0.0	   	  	  	   
    5 -   9	  	 0.0	   	  	  	   
   10 -  14	 0.3	 0.0	 0.06	 0.2	 0.1	 0.03
   15 -  19	 0.9	 0.2	 0.10	 1.0	 0.6	 0.05
   20 -  24	 1.1	 0.6	 0.06	 1.2	 1.0	 0.02
   25 -  29	 1.5	 1.2	 0.03	 1.5	 1.8	-0.02
   30 -  34	 3.2	 2.2	 0.06	 2.8	 3.8	-0.05
   35 -  39	 5.0	 3.4	 0.08	 4.8	 5.6	-0.04
   40 -  44	 7.3	 5.7	 0.06	 7.2	 7.0	 0.01
   45 -  49	11.7	10.0	 0.06	10.6	11.8	-0.04
   50 -  54	12.7	13.6	-0.03	12.8	12.4	 0.01
   55 -  59	15.9	17.3	-0.04	16.0	17.1	-0.03
   60 -  64	15.3	15.2	 0.00	15.3	13.3	 0.06
   65 -  69	 7.8	 9.4	-0.06	 7.6	 8.2	-0.02
   70 -  74	 5.1	 7.4	-0.10	 5.6	 5.5	 0.00
   75 -  79	 6.4	 7.6	-0.04	 7.3	 5.4	 0.08
   80 -  84	 4.3	 4.8	-0.02	 4.4	 4.5	-0.01
   85 -  89	 1.5	 1.5	 0.00	 1.6	 1.7	-0.01
Gender: female	72.1	59.0	 0.28	69.9	71.3	-0.03
Medical history: General	  	  	   	  	  	   
  Acute respiratory disease	38.2	31.0	 0.15	36.7	38.3	-0.03
  Attention deficit hyperactivity disorder	 4.3	 1.3	 0.19	 4.0	 4.2	-0.01
  Chronic liver disease	 3.3	 2.8	 0.03	 3.5	 3.3	 0.01
  Chronic obstructive lung disease	11.0	 9.1	 0.06	11.6	11.3	 0.01
  Crohn's disease	 0.9	 0.5	 0.05	 0.7	 0.9	-0.02
  Dementia	 2.7	 2.2	 0.03	 3.0	 3.2	-0.01
  Depressive disorder	39.6	17.5	 0.51	38.7	46.4	-0.16
  Diabetes mellitus	18.7	30.3	-0.27	20.8	19.3	 0.04
  Gastroesophageal reflux disease	22.2	18.5	 0.09	20.6	23.5	-0.07
  Gastrointestinal hemorrhage	 4.7	 3.9	 0.04	 3.9	 5.1	-0.06
  Human immunodeficiency virus infection	 0.4	 0.4	 0.00	 0.5	 0.6	-0.02
  Hyperlipidemia	48.9	53.1	-0.08	49.4	47.8	 0.03
  Hypertensive disorder	50.7	65.4	-0.30	52.7	50.5	 0.04
  Lesion of liver	 1.1	 1.1	 0.00	 1.1	 1.7	-0.04
  Obesity	13.0	13.3	-0.01	13.4	13.5	-0.01
  Osteoarthritis	33.2	36.8	-0.08	33.9	35.1	-0.02
  Pneumonia	 5.2	 5.1	 0.00	 5.8	 5.7	 0.01
  Psoriasis	 1.8	 1.3	 0.04	 1.9	 1.3	 0.05
  Renal impairment	 8.6	10.1	-0.05	 9.3	 9.8	-0.02
  Rheumatoid arthritis	 2.8	 3.0	-0.01	 2.7	 3.6	-0.05
  Schizophrenia	 1.3	 0.3	 0.11	 1.4	 1.6	-0.01
  Ulcerative colitis	 0.6	 0.5	 0.02	 0.6	 0.7	-0.01
  Urinary tract infectious disease	16.7	13.4	 0.09	16.8	16.5	 0.01
  Viral hepatitis C	 1.2	 1.2	 0.00	 1.2	 1.3	-0.01
  Visual system disorder	34.5	30.9	 0.08	35.6	36.3	-0.02
Medical history: Cardiovascular disease	  	  	   	  	  	   
  Atrial fibrillation	 3.7	 4.2	-0.03	 3.9	 4.1	-0.01
  Cerebrovascular disease	10.3	10.9	-0.02	10.8	11.9	-0.03
  Coronary arteriosclerosis	12.7	15.9	-0.09	13.0	13.0	 0.00
  Heart disease	29.6	32.9	-0.07	29.9	29.3	 0.01
  Heart failure	 5.7	 7.7	-0.08	 5.8	 7.6	-0.07
  Ischemic heart disease	 8.2	10.6	-0.08	 8.5	 8.7	 0.00
  Peripheral vascular disease	16.9	19.2	-0.06	18.1	16.6	 0.04
  Pulmonary embolism	 0.6	 0.7	-0.02	 0.7	 0.9	-0.01
  Venous thrombosis	 2.9	 2.8	 0.01	 2.8	 2.8	 0.00
Medical history: Neoplasms	  	  	   	  	  	   
  Hematologic neoplasm	 1.3	 1.4	-0.01	 1.4	 1.7	-0.02
  Malignant lymphoma	 0.2	 0.5	-0.05	 0.3	 0.4	-0.02
  Malignant neoplasm of anorectum	 0.1	 0.2	-0.03	 0.1	 0.2	-0.03
  Malignant neoplastic disease	 9.7	 9.0	 0.02	 9.7	 9.7	 0.00
  Malignant tumor of breast	 2.0	 1.6	 0.03	 1.9	 2.3	-0.03
  Malignant tumor of colon	 0.6	 0.5	 0.01	 0.5	 0.6	-0.01
  Malignant tumor of lung	 0.4	 0.4	-0.01	 0.3	 0.6	-0.03
  Malignant tumor of urinary bladder	 0.4	 0.3	 0.01	 0.4	 0.3	 0.02
  Primary malignant neoplasm of prostate	 1.2	 1.1	 0.01	 1.3	 0.6	 0.07
Medication use	  	  	   	  	  	   
  Agents acting on the renin-angiotensin system	29.9	32.2	-0.05	30.9	29.0	 0.04
  Antibacterials for systemic use	69.9	59.4	 0.22	68.3	70.3	-0.04
  Antidepressants	68.3	39.3	 0.61	66.6	73.9	-0.16
  Antiepileptics	41.4	16.7	 0.56	35.2	41.2	-0.12
  Antiinflammatory and antirheumatic products	38.0	39.7	-0.03	38.2	40.1	-0.04
  Antineoplastic agents	 2.3	 2.4	-0.01	 2.3	 3.3	-0.06
  Antipsoriatics	 0.9	 0.9	 0.01	 0.9	 1.1	-0.03
  Antithrombotic agents	37.3	32.5	 0.10	36.2	38.3	-0.04
  Beta blocking agents	32.5	33.8	-0.03	33.4	32.3	 0.02
  Calcium channel blockers	17.2	29.5	-0.29	18.7	17.2	 0.04
  Diuretics	30.4	39.7	-0.20	32.0	29.9	 0.05
  Drugs for acid related disorders	36.6	30.4	 0.13	35.0	38.3	-0.07
  Drugs for obstructive airway diseases	33.2	26.7	 0.14	32.1	34.2	-0.04
  Drugs used in diabetes	14.9	26.5	-0.29	16.7	14.9	 0.05
  Immunosuppressants	 4.4	 3.7	 0.04	 4.3	 5.4	-0.05
  Lipid modifying agents	39.2	46.0	-0.14	39.9	39.7	 0.00
  Opioids	32.4	26.6	 0.13	31.9	32.7	-0.02
  Psycholeptics	61.5	36.6	 0.51	57.6	63.4	-0.12
  Psychostimulants, agents used for adhd and nootropics	33.6	18.1	 0.36	30.4	33.8	-0.07
